News | March 26, 2024
Combination shows consistent benefit across prespecified post-progression outcomes
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
Both organisations enter into a long- term collaboration to expand patient access in India
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Subscribe To Our Newsletter & Stay Updated
